Prestige Consumer Healthcare (PBH) Intangibles (2011 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Intangibles came in at $2.3 billion in Q4 2025, little changed year-on-year from $2.3 billion in Q4 2024, and little changed quarter-over-quarter from $2.3 billion in Q3 2025.
Prestige Consumer Healthcare (PBH) Intangibles (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Intangibles history runs 15 years deep, the most recent figure standing at $2.3 billion for Q4 2025.
- On a quarterly basis, Intangibles changed 0.39% year-over-year to $2.3 billion in Q4 2025; TTM through Dec 2025 was $2.3 billion, a 0.39% change from a year earlier, with the FY2025 full-year figure at $2.3 billion, down 1.09% from the prior year.
- Intangibles steadied at $2.3 billion in Q4 2025 per PBH's latest filing, from $2.3 billion in the prior quarter.
- Across five years, Intangibles topped out at $2.7 billion in Q4 2021 and bottomed at $2.3 billion in Q3 2025.
- The 5-year median for Intangibles is $2.3 billion (2023), against an average of $2.4 billion.
- Across the five-year window, Intangibles advanced 8.94% in 2021 and decreased 13.15% in 2023, its largest moves.
- Year by year, Intangibles stood at $2.7 billion in 2021, then slipped by 1.23% to $2.7 billion in 2022, then slipped by 12.8% to $2.3 billion in 2023, then retreated by 0.77% to $2.3 billion in 2024, then dropped by 0.39% to $2.3 billion in 2025.
- Per Business Quant, the three latest PBH Intangibles figures stand at $2.3 billion (Q4 2025), $2.3 billion (Q3 2025), and $2.3 billion (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 2.30 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.30 Bn |
| Sep 30, 2025 | 2.29 Bn |
| Jun 30, 2025 | 2.29 Bn |
| Mar 31, 2025 | 2.30 Bn |
| Dec 31, 2024 | 2.31 Bn |
| Sep 30, 2024 | 2.32 Bn |
| Jun 30, 2024 | 2.32 Bn |
| Mar 31, 2024 | 2.32 Bn |
| Dec 31, 2023 | 2.33 Bn |
| Sep 30, 2023 | 2.33 Bn |
| Jun 30, 2023 | 2.34 Bn |
| Mar 31, 2023 | 2.34 Bn |
| Dec 31, 2022 | 2.67 Bn |
| Sep 30, 2022 | 2.67 Bn |
| Jun 30, 2022 | 2.68 Bn |
| Mar 31, 2022 | 2.70 Bn |
| Dec 31, 2021 | 2.70 Bn |
| Sep 30, 2021 | 2.69 Bn |
| Jun 30, 2021 | 2.47 Bn |
| Mar 31, 2021 | 2.48 Bn |